Symbols / PAHC Stock $32.43 -1.85% Phibro Animal Health Corporation

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
PAHC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Jack Clifford Bendheim
Exch · Country NGM · United States
Market Cap 1.32B
Enterprise Value 2.03B
Income 95.23M
Sales 1.50B
FCF (ttm) -17.68M
Book/sh 8.92
Cash/sh 1.93
Employees 2,475
Insider 10d —
IPO Apr 11, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 20.60%
P/E 13.92
Forward P/E 9.70
PEG 1.68
P/S 0.88
P/B 3.64
P/C —
EV/EBITDA 8.63
EV/Sales 1.35
Quick Ratio 1.06
Current Ratio 3.17
Debt/Eq 217.97
LT Debt/Eq —
EPS (ttm) 2.33
EPS next Y 3.34
EPS Growth 15.70%
Revenue Growth 10.30%
EPS Gr Q/Q 15.10%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-05-06
ROA 8.40%
ROE 30.34%
ROIC —
Gross Margin 32.57%
Oper. Margin 12.56%
Profit Margin 6.35%
Shs Outstand 21.07M
Shs Float 20.87M
Insider Own 0.85%
Instit Own 99.66%
Short Float 6.65%
Short Ratio 2.84
Short Interest 1.18M
52W High 60.08
vs 52W High -46.02%
52W Low 22.85
vs 52W Low 41.94%
Beta 0.46
Impl. Vol. 35.50%
Rel Volume 0.74
Avg Volume 363.32K
Volume 267.26K
Target (mean) $45.60
Tgt Median $44.00
Tgt Low $38.00
Tgt High $58.00
# Analysts 5
Recom None
Prev Close $33.04
Price $32.43
Change -1.85%
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$45.60
Mean price target
2. Current target
$32.43
Latest analyst target
3. DCF / Fair value
$-15.10
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$32.43
Low
$38.00
High
$58.00
Mean
$45.60

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-14 main Citigroup Neutral → Neutral $44
2026-04-15 init Citigroup — → Neutral $62
2025-11-07 main JP Morgan Overweight → Overweight $50
2025-08-29 main B of A Securities Underperform → Underperform $27
2025-07-07 up JP Morgan Neutral → Overweight $35
2025-06-25 main Morgan Stanley Equal-Weight → Equal-Weight $26
2025-05-08 main Morgan Stanley Equal-Weight → Equal-Weight $21
2025-02-10 main Barclays Underweight → Underweight $22
2024-12-17 main Morgan Stanley Equal-Weight → Equal-Weight $25
2024-11-12 main Barclays Underweight → Underweight $20
2024-09-10 init JP Morgan — → Neutral $22
2024-08-30 main B of A Securities Underperform → Underperform $15
2024-05-10 main Barclays Underweight → Underweight $13
2023-11-09 main Morgan Stanley Equal-Weight → Equal-Weight $16
2023-09-01 reit Roth MKM Buy → Buy $21
2023-08-31 main Morgan Stanley Equal-Weight → Equal-Weight $17
2023-08-29 reit Roth MKM Buy → Buy $21
2023-07-27 reit Morgan Stanley Equal-Weight → Equal-Weight $18
2023-05-04 main Morgan Stanley — → Equal-Weight $18
2023-02-09 main Morgan Stanley — → Equal-Weight $19
News
RSS: Latest PAHC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-29 CORCORAN E. THOMAS Director — 10,000 $31.77 $317,700
2026-05-07 BENDHEIM JACK C Chief Executive Officer — 18,608 $47.59 $1,016,228
2026-04-30 BENDHEIM JACK CLIFFORD Chief Executive Officer — 21,120 $52.65 $1,137,593
2026-04-23 BENDHEIM JACK C Chief Executive Officer — 21,120 $54.07 $1,157,091
2026-04-16 BENDHEIM JACK C Chief Executive Officer — 21,120 $54.56 $1,201,595
2026-04-16 BENDHEIM JACK C Chief Executive Officer — 100,000 — —
2026-03-31 BENDHEIM JACK CLIFFORD Chief Executive Officer — 14,080 $53.54 $756,834
2026-03-26 BENDHEIM JACK C Chief Executive Officer — 21,120 $52.88 $1,166,105
2026-03-19 BENDHEIM JACK C Chief Executive Officer — 22,880 $51.66 $1,198,818
2026-03-13 BENDHEIM JACK CLIFFORD Chief Executive Officer — 5,280 $48.91 $258,245
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
1,296.21
+27.37%
1,017.68
+4.07%
977.89
+3.78%
942.26
Operating Revenue
1,296.21
+27.37%
1,017.68
+4.07%
977.89
+3.78%
942.26
Cost Of Revenue
896.27
+27.21%
704.59
+3.67%
679.65
+3.47%
656.86
Reconciled Cost Of Revenue
896.27
+27.21%
704.59
+3.67%
679.65
+3.47%
656.86
Gross Profit
399.94
+27.74%
313.09
+4.98%
298.24
+4.50%
285.40
Operating Expense
289.48
+11.43%
259.78
+14.75%
226.39
+9.68%
206.41
Selling General And Administration
289.48
+11.43%
259.78
+14.75%
226.39
+9.68%
206.41
Total Expenses
1,185.75
+22.96%
964.36
+6.44%
906.04
+4.95%
863.27
Operating Income
110.47
+107.19%
53.31
-25.79%
71.85
-9.04%
78.99
Total Operating Income As Reported
110.47
+107.19%
53.31
-25.79%
71.85
-9.04%
78.99
EBITDA
146.85
+112.62%
69.06
-34.86%
106.03
-9.48%
117.13
Normalized EBITDA
154.72
+66.49%
92.93
-14.34%
108.49
-3.06%
111.92
Reconciled Depreciation
45.60
+26.06%
36.18
+6.37%
34.01
+4.00%
32.70
EBIT
101.24
+207.86%
32.89
-54.34%
72.02
-14.70%
84.43
Total Unusual Items
-7.87
+67.02%
-23.86
-872.02%
-2.46
-147.07%
5.22
Total Unusual Items Excluding Goodwill
-7.87
+67.02%
-23.86
-872.02%
-2.46
-147.07%
5.22
Net Income
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Pretax Income
67.99
+522.87%
10.92
-79.81%
54.07
-25.24%
72.33
Net Non Operating Interest Income Expense
-34.60
-86.67%
-18.54
-20.98%
-15.32
-29.02%
-11.88
Interest Expense Non Operating
33.25
+51.34%
21.97
+22.40%
17.95
+48.33%
12.10
Net Interest Income
-34.60
-86.67%
-18.54
-20.98%
-15.32
-29.02%
-11.88
Interest Expense
33.25
+51.34%
21.97
+22.40%
17.95
+48.33%
12.10
Interest Income Non Operating
2.62
-41.39%
4.47
+33.35%
3.35
+311.15%
0.82
Interest Income
2.62
-41.39%
4.47
+33.35%
3.35
+311.15%
0.82
Other Income Expense
-7.87
+67.02%
-23.86
-872.02%
-2.46
-147.07%
5.22
Gain On Sale Of Security
-7.87
+67.02%
-23.86
-872.02%
-2.46
-147.07%
5.22
Tax Provision
19.73
+132.11%
8.50
-60.40%
21.46
-7.29%
23.15
Tax Rate For Calcs
0.00
+38.10%
0.00
-47.10%
0.00
+24.06%
0.00
Tax Effect Of Unusual Items
-2.28
+54.46%
-5.01
-414.16%
-0.97
-158.39%
1.67
Net Income Including Noncontrolling Interests
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Net Income From Continuing Operation Net Minority Interest
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Net Income From Continuing And Discontinued Operation
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Net Income Continuous Operations
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Normalized Income
53.85
+153.21%
21.27
-37.61%
34.09
-25.30%
45.63
Net Income Common Stockholders
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Diluted EPS
1.19
+1883.33%
0.06
-92.59%
0.81
-33.06%
1.21
Basic EPS
1.19
+1883.33%
0.06
-92.59%
0.81
-33.06%
1.21
Basic Average Shares
40.50
-0.01%
40.50
+0.00%
40.50
+0.01%
40.50
Diluted Average Shares
40.70
+0.44%
40.52
+0.05%
40.50
+0.01%
40.50
Diluted NI Availto Com Stockholders
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Total Other Finance Cost
3.98
+282.21%
1.04
+43.05%
0.73
+23.22%
0.59
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
1,360.90
+38.56%
982.18
+1.11%
971.40
+4.26%
931.70
Current Assets
810.61
+34.88%
601.00
+2.61%
585.72
+3.44%
566.23
Cash Cash Equivalents And Short Term Investments
77.04
-32.78%
114.61
+41.01%
81.28
-10.92%
91.25
Cash And Cash Equivalents
68.04
-3.65%
70.61
+71.05%
41.28
-44.40%
74.25
Other Short Term Investments
9.00
-79.55%
44.00
+10.00%
40.00
+135.29%
17.00
Receivables
227.98
+34.54%
169.45
+3.65%
163.48
-1.84%
166.54
Accounts Receivable
227.98
+34.54%
169.45
+3.65%
163.48
-1.84%
166.54
Gross Accounts Receivable
230.24
+34.71%
170.91
+3.54%
165.07
-2.93%
170.05
Allowance For Doubtful Accounts Receivable
-2.26
-54.48%
-1.46
+8.11%
-1.59
+54.70%
-3.51
Inventory
444.43
+67.13%
265.91
-4.20%
277.57
+7.10%
259.16
Raw Materials
162.63
+123.39%
72.80
-13.67%
84.33
-3.10%
87.03
Work In Process
27.98
+18.82%
23.55
+5.37%
22.35
+44.49%
15.47
Finished Goods
253.82
+49.69%
169.56
-0.78%
170.89
+9.08%
156.66
Other Current Assets
61.16
+19.87%
51.02
-19.52%
63.39
+28.61%
49.29
Total Non Current Assets
550.29
+44.36%
381.19
-1.16%
385.67
+5.53%
365.47
Net PPE
396.03
+64.39%
240.90
+4.14%
231.33
+13.86%
203.17
Gross PPE
674.99
+38.81%
486.26
-1.76%
494.95
+11.44%
444.13
Accumulated Depreciation
-278.96
-13.70%
-245.35
+6.93%
-263.63
-9.40%
-240.97
Properties
0.00
0.00
0.00
0.00
Land And Improvements
33.05
+7.92%
30.62
+10.11%
27.81
+133.19%
11.93
Buildings And Improvements
175.89
+46.37%
120.17
+14.25%
105.18
+17.42%
89.58
Machinery Furniture Equipment
391.99
+43.08%
273.96
-6.00%
291.45
+6.25%
274.30
Construction In Progress
32.72
+36.93%
23.89
-31.23%
34.74
+13.36%
30.65
Other Properties
41.34
+9.93%
37.60
+5.16%
35.76
-5.10%
37.68
Goodwill And Other Intangible Assets
96.11
-3.49%
99.59
-8.01%
108.26
-7.54%
117.09
Goodwill
59.65
+9.33%
54.56
+2.41%
53.27
+0.09%
53.23
Other Intangible Assets
36.47
-19.02%
45.03
-18.10%
54.99
-13.90%
63.86
Investments And Advances
11.69
+1.75%
11.49
+3.55%
11.09
+7.23%
10.35
Long Term Equity Investment
5.14
-0.79%
5.18
+3.10%
5.03
+15.25%
4.36
Other Investments
6.55
+3.84%
6.30
+3.92%
6.07
+1.39%
5.98
Non Current Deferred Assets
25.55
+31.89%
19.37
+122.37%
8.71
+48.93%
5.85
Non Current Deferred Taxes Assets
25.55
+31.89%
19.37
+122.37%
8.71
+48.93%
5.85
Non Current Prepaid Assets
0.61
-62.94%
1.65
-75.12%
6.62
+12.06%
5.91
Other Non Current Assets
20.21
+146.89%
8.19
-13.25%
9.44
-6.86%
10.13
Total Liabilities Net Minority Interest
1,075.22
+48.19%
725.54
+5.32%
688.89
+2.93%
669.26
Current Liabilities
293.47
+43.76%
204.15
+15.99%
176.00
-7.77%
190.83
Payables And Accrued Expenses
185.10
+65.65%
111.74
+12.38%
99.43
-14.72%
116.60
Payables
146.60
+65.65%
88.50
+7.25%
82.52
-19.74%
102.81
Accounts Payable
138.20
+61.51%
85.57
+15.86%
73.85
-22.74%
95.60
Current Accrued Expenses
38.50
+65.65%
23.24
+37.39%
16.92
+22.67%
13.79
Employee Benefits
10.85
-10.51%
12.13
-7.06%
13.05
-5.32%
13.78
Pensionand Other Post Retirement Benefit Plans Current
51.76
+37.61%
37.61
+28.11%
29.36
-14.35%
34.28
Total Tax Payable
8.40
+186.49%
2.93
-66.17%
8.66
+20.14%
7.21
Current Debt And Capital Lease Obligation
25.38
-31.88%
37.26
+31.42%
28.35
+34.66%
21.05
Current Debt
16.25
-45.46%
29.80
+33.64%
22.30
+48.63%
15.00
Other Current Borrowings
16.25
-45.46%
29.80
+33.64%
22.30
+48.63%
15.00
Current Capital Lease Obligation
9.13
+22.35%
7.46
+23.24%
6.05
+0.03%
6.05
Other Current Liabilities
31.24
+78.09%
17.54
-6.99%
18.86
-0.24%
18.90
Total Non Current Liabilities Net Minority Interest
781.75
+49.93%
521.39
+1.66%
512.89
+7.20%
478.43
Long Term Debt And Capital Lease Obligation
736.17
+50.79%
488.20
+1.37%
481.62
+7.16%
449.43
Long Term Debt
702.43
+53.27%
458.29
+1.27%
452.54
+8.28%
417.93
Long Term Capital Lease Obligation
33.74
+12.79%
29.91
+2.88%
29.08
-7.72%
31.51
Defined Pension Benefit
—
—
—
0.00
Non Current Pension And Other Postretirement Benefit Plans
10.85
-10.51%
12.13
-7.06%
13.05
-5.32%
13.78
Non Current Deferred Liabilities
19.47
+36.95%
14.22
+17.06%
12.15
+31.11%
9.26
Non Current Deferred Taxes Liabilities
19.47
+36.95%
14.22
+17.06%
12.15
+31.11%
9.26
Other Non Current Liabilities
11.36
+65.95%
6.85
+12.67%
6.08
+2.17%
5.95
Stockholders Equity
285.68
+11.32%
256.64
-9.16%
282.51
+7.65%
262.44
Common Stock Equity
285.68
+11.32%
256.64
-9.16%
282.51
+7.65%
262.44
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
40.53
+0.07%
40.50
+0.00%
40.50
+0.00%
40.50
Ordinary Shares Number
40.53
+0.07%
40.50
+0.00%
40.50
+0.00%
40.50
Additional Paid In Capital
137.00
+0.53%
136.28
+0.35%
135.80
+0.00%
135.80
Retained Earnings
272.70
+11.81%
243.89
-6.53%
260.91
+5.31%
247.75
Gains Losses Not Affecting Retained Earnings
-124.02
-0.40%
-123.53
-8.16%
-114.21
+5.70%
-121.11
Other Equity Adjustments
-1.71
-117.40%
9.80
-46.69%
18.38
+17.76%
15.61
Total Equity Gross Minority Interest
285.68
+11.32%
256.64
-9.16%
282.51
+7.65%
262.44
Total Capitalization
988.12
+38.21%
714.93
-2.74%
735.05
+8.04%
680.37
Working Capital
517.13
+30.31%
396.85
-3.14%
409.72
+9.14%
375.40
Invested Capital
1,004.37
+34.86%
744.73
-1.67%
757.35
+8.91%
695.37
Total Debt
761.55
+44.93%
525.46
+3.04%
509.97
+8.39%
470.48
Net Debt
650.65
+55.85%
417.47
-3.71%
433.56
+20.88%
358.68
Capital Lease Obligations
42.87
+14.69%
37.38
+6.39%
35.13
-6.47%
37.56
Net Tangible Assets
189.57
+20.70%
157.05
-9.87%
174.25
+19.88%
145.35
Tangible Book Value
189.57
+20.70%
157.05
-9.87%
174.25
+19.88%
145.35
Derivative Product Liabilities
3.88
0.00
—
—
Financial Assets
0.09
0.00
-100.00%
10.22
-21.20%
12.98
Foreign Currency Translation Adjustments
-113.45
+8.51%
-124.00
-7.77%
-115.06
+3.34%
-119.03
Minimum Pension Liabilities
-17.03
+2.64%
-17.49
+31.94%
-25.70
+0.61%
-25.86
Unrealized Gain Loss
8.17
+0.00%
8.17
+0.00%
8.17
+0.00%
8.17
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
80.12
-8.53%
87.59
+558.11%
13.31
-57.94%
31.65
Cash Flow From Continuing Operating Activities
80.12
-8.53%
87.59
+558.11%
13.31
-57.94%
31.65
Net Income From Continuing Operations
48.26
+1897.68%
2.42
-92.59%
32.61
-33.69%
49.17
Depreciation Amortization Depletion
45.60
+26.06%
36.18
+6.37%
34.01
+4.00%
32.70
Depreciation
37.76
+42.41%
26.52
+9.05%
24.32
+2.25%
23.78
Amortization Cash Flow
7.84
-18.82%
9.66
-0.36%
9.70
+8.65%
8.92
Depreciation And Amortization
45.60
+26.06%
36.18
+6.37%
34.01
+4.00%
32.70
Amortization Of Intangibles
7.84
-18.82%
9.66
-0.36%
9.70
+8.65%
8.92
Other Non Cash Items
6.05
+1226.82%
-0.54
-150.61%
1.06
-13.39%
1.23
Pension And Employee Benefit Expense
0.00
-100.00%
10.67
0.00
0.00
Stock Based Compensation
0.72
+50.95%
0.47
0.00
0.00
Asset Impairment Charge
5.33
0.00
0.00
—
Deferred Tax
-4.88
+37.77%
-7.84
-176.25%
-2.84
-252.11%
-0.81
Deferred Income Tax
-4.88
+37.77%
-7.84
-176.25%
-2.84
-252.11%
-0.81
Operating Gains Losses
0.60
-97.48%
23.79
+328.77%
-10.40
-72.98%
-6.01
Gain Loss On Investment Securities
—
—
—
-1.20
Net Foreign Currency Exchange Gain Loss
0.60
-95.42%
13.11
+226.12%
-10.40
-116.26%
-4.81
Change In Working Capital
-21.56
-165.11%
33.11
+180.50%
-41.13
+7.85%
-44.64
Change In Receivables
-55.21
-536.18%
-8.68
-262.66%
5.33
+122.58%
-23.62
Changes In Account Receivables
-55.21
-536.18%
-8.68
-262.66%
5.33
+122.58%
-23.62
Change In Inventory
-44.29
-1777.17%
2.64
+123.53%
-11.22
+76.12%
-47.00
Change In Payables And Accrued Expense
92.71
+283.29%
24.19
+184.64%
-28.58
-196.84%
29.51
Change In Accrued Expense
47.16
+286.90%
12.19
+312.09%
-5.75
-282.33%
3.15
Change In Payable
45.55
+279.63%
12.00
+152.56%
-22.83
-186.62%
26.36
Change In Account Payable
45.55
+279.63%
12.00
+152.56%
-22.83
-186.62%
26.36
Change In Other Current Assets
-14.77
-198.74%
14.96
+324.35%
-6.67
-89.19%
-3.52
Investing Cash Flow
-288.69
-499.01%
-48.19
+34.89%
-74.02
-227.77%
-22.58
Cash Flow From Continuing Investing Activities
-288.69
-499.01%
-48.19
+34.89%
-74.02
-227.77%
-22.58
Capital Expenditure
-38.29
+7.14%
-41.24
+20.38%
-51.79
-39.82%
-37.04
Capital Expenditure Reported
-38.29
+7.14%
-41.24
+20.38%
-51.79
-39.82%
-37.04
Net Investment Purchase And Sale
35.00
+975.00%
-4.00
+82.61%
-23.00
-184.09%
27.35
Purchase Of Investment
-14.00
+78.63%
-65.52
-63.81%
-40.00
+37.60%
-64.10
Sale Of Investment
49.00
-20.35%
61.52
+261.90%
17.00
-81.41%
91.45
Net Business Purchase And Sale
-286.53
-8630.32%
-3.28
0.00
+100.00%
-13.51
Purchase Of Business
-286.53
-8630.32%
-3.28
0.00
+100.00%
-13.51
Net Other Investing Changes
1.13
+247.85%
0.33
-57.99%
0.78
+25.16%
0.62
Financing Cash Flow
207.13
+3160.49%
-6.77
-125.08%
26.99
+65.13%
16.34
Cash Flow From Continuing Financing Activities
207.13
+3160.49%
-6.77
-125.08%
26.99
+65.13%
16.34
Net Issuance Payments Of Debt
235.99
+1757.43%
12.71
-70.24%
42.69
+5.07%
40.62
Issuance Of Debt
1,182.00
+328.26%
276.00
-15.34%
326.00
+9.76%
297.00
Repayment Of Debt
-946.01
-259.30%
-263.30
+7.07%
-283.31
-10.51%
-256.38
Long Term Debt Issuance
1,182.00
+328.26%
276.00
-15.34%
326.00
+9.76%
297.00
Long Term Debt Payments
-946.01
-259.30%
-263.30
+7.07%
-283.31
-10.51%
-256.38
Net Long Term Debt Issuance
235.99
+1757.43%
12.71
-70.24%
42.69
+5.07%
40.62
Short Term Debt Issuance
—
—
—
297.00
Short Term Debt Payments
—
—
—
-247.00
Net Short Term Debt Issuance
—
—
—
50.00
Net Common Stock Issuance
—
—
—
—
Common Stock Dividend Paid
-19.45
-0.04%
-19.44
+0.00%
-19.44
+0.00%
-19.44
Cash Dividends Paid
-19.45
-0.04%
-19.44
+0.00%
-19.44
+0.00%
-19.44
Net Other Financing Charges
-9.40
-30232.26%
-0.03
-100.83%
3.74
+177.36%
-4.84
Changes In Cash
-1.43
-104.38%
32.63
+196.77%
-33.72
-232.71%
25.41
Effect Of Exchange Rate Changes
-1.14
+65.33%
-3.30
-537.67%
0.75
+154.88%
-1.37
Beginning Cash Position
70.61
+71.05%
41.28
-44.40%
74.25
+47.87%
50.21
End Cash Position
68.04
-3.65%
70.61
+71.05%
41.28
-44.40%
74.25
Free Cash Flow
41.83
-9.76%
46.36
+220.46%
-38.48
-613.33%
-5.39
Interest Paid Supplemental Data
32.07
+85.90%
17.25
+18.37%
14.57
+30.61%
11.16
Income Tax Paid Supplemental Data
13.40
-13.16%
15.43
-24.40%
20.41
+14.32%
17.85
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category